St. Louis-based Ascension, which signed a definitive agreement on June 17 to acquire ASC operator AmSurg, reported a fiscal 2025 operating loss of $490.9 million (a -1.6% operating margin), a significant improvement from its $1.8 billion loss (-6.3% margin) the prior year.
Here are five key takeaways from Ascension’s quarterly performance
1. Operating results for 2025 included $81 million in one-time, non-cash write-downs and other nonrecurring losses, down from $402 million in such charges in 2024.
2. Total revenue declined 11.3% year over year to $25.3 billion for the 12 months ending June 30. On a same-facility basis, adjusted to reflect portfolio changes, total operating revenue rose 6.6%.
3. Total operating expenses fell 14.1% year over year to $25.83 billion in 2025. When viewed on a same-facility basis, expenses ticked up just 0.1% from the prior year.
4. Salaries, wages and benefits declined 15.2% overall and 1.5% on a same-facility basis. The system attributed these decreases to workforce stabilization and labor efficiency efforts, which have helped reduce staff turnover.
5. Ascension posted net income of $918 million in 2025, a sharp turnaround from a net loss of $1.1 billion in 2024.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
